POTASSIUM PHOSPHATES
Generic: POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,
Amneal Pharmaceuticals Private LimitedManufacturer
INTRAVENOUSRoute
POTASSIUM PHOSPHATEActive Substance
2023-10-10Original Approval
POTASSIUM PHOSPHATES is FDA application ANDA216344, sponsored by AMNEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DIARRHOEA
64 reports
2
NAUSEA
62 reports
3
PYREXIA
59 reports
4
PNEUMONIA
57 reports
5
CYTOKINE RELEASE SYNDROME
51 reports
6
OFF LABEL USE
50 reports
7
VOMITING
49 reports
8
HYPOTENSION
46 reports
9
DYSPNOEA
44 reports
10
ACUTE KIDNEY INJURY
42 reports